Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia

Area of Science:

• Immunology
• Hematology
• Molecular Biology

Background:

• B-cell receptor (BCR) signaling is crucial in chronic lymphocytic leukemia (CLL) pathogenesis.
• CLL cells primarily express IgM and IgD BCR isotypes, but their distinct functional roles are not fully understood.

Purpose of the Study:

• To investigate and compare the functional outcomes of IgM and IgD BCR signaling in CLL cells.
• To explore these signaling differences in both freshly isolated cells and a microenvironment-mimicking model.

Main Methods:

• Analysis of signaling pathways (ERK, HS1, F-actin) in CLL cells stimulated via IgM or IgD.
• Assessment of downstream functional responses: cell survival, chemokine secretion (CCL3, CCL4), and receptor expression.
• Coculture of CLL cells with nurselike cells to simulate the lymph node microenvironment.
• Evaluation of the effect of Bruton's tyrosine kinase (BTK) inhibitor ibrutinib on BCR signaling.

Main Results:

• IgM signaling induced sustained ERK activation, promoted CLL cell survival, and increased CCL3/CCL4 chemokine secretion.
• IgD signaling triggered HS1 activation and F-actin polymerization, leading to rapid BCR internalization and impaired downstream signaling.
• Distinct IgM and IgD signaling outcomes were observed in both isolated CLL cells and cocultured cells.
• Ibrutinib effectively inhibited both IgM and IgD BCR signaling pathways.

Conclusions:

• IgM and IgD BCR isotypes elicit significantly different functional responses in CLL cells.
• These findings provide new insights into BCR signaling regulation in CLL and its potential therapeutic targeting.